Ph 2 Maintenance Trial: Ixazomib vs Ixazomib-Lenalidomide for MM Patients

NCT03733691 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped Insufficient enrollment

Conditions

Newly Diagnosed Multiple Myeloma

Interventions

DRUG: Ixazomib
DRUG: Lenalidomide

Sponsor

Oncotherapeutics

Collaborators

[object Object]